Dr. Emily Whitcomb headshot

Emily L. Whitcomb, MD, MAS

Clinician Investigator

Obstetrics-Gynecology

Division of Female Pelvic Medicine and Reconstructive Surgery

Orange County–Irvine Medical Center

626-564-5667

Clinical.Trials@kp.org

Biography

Dr. Emily Whitcomb is a clinician investigator at the Kaiser Permanente Orange County–Irvine Medical Center in the Division of Female Pelvic Medicine and Reconstructive Surgery. Her research and practice focus on female pelvic floor disorders. She is currently the principal investigator for a prospective, multi-center, randomized, double-blinded, partial crossover trial of percutaneous tibial nerve stimulation in patients with overactive bladder.

She is also the principal investigator for the American Urogynecologic Society Quality Improvement and Outcomes Research Network, a multi-center research group focused on development, implementation, and publication of quality outcome research data. She serves as the Orange County vice-chair for the Kaiser Permanente Southern California Regional Research Committee.

Dr. Whitcomb is actively engaged in training future urogynecologists in partnership with the University of California, Irvine. She is the residency coordinator in obstetrics and gynecology and the associate director of the fellowship training program in female pelvic medicine and reconstructive

...

surgery. She works with Orange-Aid as a peer counselor for Orange County physicians experiencing adverse clinical events and serves as an oral board examiner for the American Board of Obstetrics and Gynecology.

Areas of Focus

  • Female pelvic floor disorders
  • Quality metric development in urogynecology

Education

Residency, Fellowship
University of California, San Diego
San Diego, California
MD
Johns Hopkins University
Baltimore, Maryland
MAS
University of California, San Diego
San Diego, California

Honors and Awards

Top Doctors 2018 and 2019, Recognized as Physician of Excellence in Orange Coast Magazine
Clinician Investigator Award, Southern California Permanente Medical Group, 2017–2019